Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for Transfer

NAActive, not recruitingINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

June 13, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

January 31, 2025

Conditions
Infertility
Interventions
DEVICE

Hera Score

The device uses patient metadata (patient age, day of image capture) and a software algorithm to analyze features of the blastocyst morphology to provide adjunctive information that may predict further development of the embryo to clinical pregnancy after embryo transfer.

Trial Locations (7)

32789

Center for Reproductive Medicine, Winter Park

33063

IVF Florida Reproductive Associates, Margate

78258

Aspire Fertility, San Antonio

78731

Ovation Fertility, Austin

84092

Reproductive Care Center, Sandy City

94025

CCRM, Menlo Park

94583

Reproductive Science Center, San Ramon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alife Health

INDUSTRY